Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-465
Closed -$125K 71
2023
Q3
$125K Sell
465
-232
-33% -$57.9K 0.02% 106
2023
Q2
$155K Sell
697
-60
-8% -$13.9K 0.02% 105
2023
Q1
$183K Sell
757
-71
-9% -$17.4K 0.02% 97
2022
Q4
$217K Sell
828
-543
-40% -$146K 0.03% 85
2022
Q3
$309K Buy
1,371
+202
+17% +$49K 0.04% 78
2022
Q2
$284K Buy
1,169
+811
+227% +$199K 0.03% 81
2022
Q1
$87K Sell
358
-250
-41% -$57.4K 0.01% 128
2021
Q4
$137K Buy
608
+36
+6% +$7.6K 0.02% 162
2021
Q3
$122K Sell
572
-411
-42% -$94.6K 0.02% 130
2021
Q2
$240K Buy
983
+115
+13% +$28.3K 0.04% 136
2021
Q1
$216K Sell
868
-513
-37% -$122K 0.04% 120
2020
Q4
$318K Sell
1,381
-305
-18% -$70.3K 0.13% 114
2020
Q3
$429K Buy
1,686
+77
+5% +$19.1K 0.22% 98
2020
Q2
$379K Buy
+1,609
New +$367K 0.2% 96

Other funds holding AMGN

Rock Creek Group's AMGN Position: Q4 2023 in Review

Rock Creek Group sold out of Amgen (AMGN) in Q4 2023, closing a stake of 465 shares — an estimated $125K sold.

Rock Creek Group first reported a position in AMGN in Q2 2020 and held it in 14 quarters. The position peaked at $429K in Q3 2020. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • Rock Creek Group reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
  • Rock Creek Group sold 465 Amgen shares in Q4 2023, an estimated $125K.
  • Rock Creek Group first reported a position in Amgen in Q2 2020 and held it in 14 quarters.
  • Rock Creek Group's Amgen position peaked at $429K in Q3 2020.
  • 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Rock Creek Group's 13F filing for Q4 2023, filed 13 Feb 2024.